{"database": "openregs", "table": "dockets", "rows": [["FDA-2025-P-7112", "FDA", "Requests that FDA determine whether Fluosol\u00ae (20% Intravascular Perfluorochemical Emulsion) approved under New Drug Application (NDA) 86-0909, held by Alpha Therapeutic Corporation, has been voluntarily withdrawn from sale for reasons of safety or effectiveness, pursuant to 21 CFR S 314.161", "Nonrulemaking", "2026-06-15T18:17:54Z", "0b000064b90dd2c1"]], "columns": ["id", "agency_id", "title", "docket_type", "last_modified", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2025-P-7112"], "units": {}, "query_ms": 8.92533799924422, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}